Essex Woodlands Management, Inc.
An institutional investment manager in THE WOODLANDS, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 4, 2026. SEC CIK 1542339.
- Reported value$254.2m
- Positions5
Holdings: 5 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Bioventus IncBVS | COM CL A | 09075A108 | 123 | 48.3% | 13,021,324 | Unchanged | |
| Mimedx Group IncMDXG | COM | 602496101 | 109 | 42.7% | 28,195,249 | Unchanged | |
| Eyepoint Pharmaceuticals IncEYPT | COM NEW | 30233G209 | 15.5 | 6.1% | 1,084,857 | Unchanged | |
| Tela Bio IncTELA | COM | 872381108 | 5.8 | 2.3% | 7,714,709 | Unchanged | |
| Medicinova IncMNOV | COM NEW | 58468P206 | 1.5 | 0.6% | 1,105,941 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0000908834-26-000375 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.